Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EC Ecopetrol SA

Trading 10-28 12:36:12 EDT

17.68

+0.39

+2.26%

High17.77	Low17.38	Vol943.92K
Open17.46	D1 Closing17.29	Amplitude2.26%
Mkt Cap36.35B	Tradable Cap4.19B	Total Shares2.06B
T/O16.67M	T/O Rate0.40%	Tradable Shares237.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EC","market":"US","secType":"STK","nameCN":"Ecopetrol SA","latestPrice":17.68,"timestamp":1793205365416,"preClose":17.29,"halted":0,"volume":943923,"delay":0,"changeRate":0.022556390977443642,"floatShares":237000000,"shares":2055834734,"eps":1.903,"marketStatus":"Trading","change":0.39,"latestTime":"10-28 12:36:12 EDT","open":17.4575,"high":17.765,"low":17.375,"amount":16674261.982241997,"amplitude":0.022556,"askPrice":17.69,"askSize":610,"bidPrice":17.67,"bidSize":150,"shortable":3,"etf":0,"ttmEps":1.903,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793217600000},"marketStatusCode":2,"adr":1,"adrRate":20,"listingDate":1221710400000,"exchange":"NYSE","adjPreClose":17.29,"dividendRate":0.056052,"preHourTrading":{"tag":"盘前","latestPrice":17.35,"preClose":17.29,"latestTime":"09:29 EDT","volume":3769,"amount":65473.27772499999,"timestamp":1793194163470,"change":0.06,"changeRate":0.00347,"amplitude":0.074031},"postHourTrading":{"tag":"盘后","latestPrice":17.42,"preClose":17.29,"latestTime":"19:47 EDT","volume":32297,"amount":557975.6617,"timestamp":1793144856842,"change":0.13,"changeRate":0.007519,"amplitude":0.009838},"volumeRatio":1.146234,"impliedVol":0.4788,"impliedVolPercentile":0.5299},"requestUrl":"/m/hq/s/EC","defaultTab":"news","newsList":[{"id":"2678984011","title":"Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2678984011","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678984011?lang=en_us&edition=fundamental","pubTime":"2026-10-26 20:00","pubTimestamp":1793016000,"startTime":"0","endTime":"0","summary":"- Obtaining Orphan designation from the European Commission reflects Solid’s commitment to the global development of SGT-212 for individuals living with Friedreich’s ataxia - - SGT-212 is a first-in-c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/26/3388054/0/en/solid-biosciences-announces-european-commission-orphan-designation-for-sgt-212-and-continued-progress-in-the-falcon-trial-in-friedreich-s-ataxia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","EPV","FA","BK4023","BK4539","FXN","BK4535","PRGS","SLDB","BK4157","BK4139","BK4130","IDN","BK4097","EC","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677954329","title":"Press Release: Ecopetrol's \"New Era\" Advances with the Appointment of the Executive Vice President of Energies for the Transition and Two Legal Representatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2677954329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677954329?lang=en_us&edition=fundamental","pubTime":"2026-10-22 18:43","pubTimestamp":1792665780,"startTime":"0","endTime":"0","summary":"BOGOTA, Colombia, Oct. 22, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the \"Company\") announces that its Board of Directors has appointed Armando José Cuello Navarro as Executive V","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677608183","title":"Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677608183","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677608183?lang=en_us&edition=fundamental","pubTime":"2026-10-21 23:00","pubTimestamp":1792594800,"startTime":"0","endTime":"0","summary":"Cosentyx (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common inflammatory rheumatic disease with limited advanced treatment options2-6Approval based","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/21/3385726/0/en/novartis-receives-european-commission-approval-for-cosentyx-in-polymyalgia-rheumatica-pmr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AS","EC","BK4201","PMR","EPV","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677752676","title":"Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677752676","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677752676?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:00","pubTimestamp":1792584000,"startTime":"0","endTime":"0","summary":"BOSTON, Oct.  21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/21/3385449/0/en/rhythm-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-tuesday-november-3-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DI","AVP","BK4201","EC","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676954336","title":"Acrivon Advances ACR-7280, an Optimized, AP3-Enabled, Potential First-in-Class, Oral CDK11 Inhibitor Toward IND Filing in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2676954336","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676954336?lang=en_us&edition=fundamental","pubTime":"2026-10-20 20:30","pubTimestamp":1792499400,"startTime":"0","endTime":"0","summary":"ACR-7280 demonstrated complete tumor regression in aggressive AML xenograft models Prioritized among multiple AP3-discovered, highly selective CDK11 inhibitor candidates based on potent single agent a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/20/3384416/0/en/acrivon-advances-acr-7280-an-optimized-ap3-enabled-potential-first-in-class-oral-cdk11-inhibitor-toward-ind-filing-in-first-half-of-2027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4201","ACR","IND","BK4110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675359284","title":"Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children","url":"https://stock-news.laohu8.com/highlight/detail?id=2675359284","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675359284?lang=en_us&edition=fundamental","pubTime":"2026-10-16 20:29","pubTimestamp":1792153740,"startTime":"0","endTime":"0","summary":"Final European Commission decision expected during Q4 2026COPENHAGEN, Denmark, Oct.  16, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Medicinal Pr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/16/3382571/0/en/once-weekly-transcon-cnp-navepegritide-receives-positive-chmp-opinion-for-the-treatment-of-achondroplasia-in-children.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTES","CHMP","BK4201","EC","IE00BD4GTV84.USD","EMA","CNP","BK4585","BK4087","IE00BD4GTT62.SGD","BK4208","BK4215","SPRE","IE00BJTD4V19.USD","IE00BD4GTW91.USD","IE00BJTD4N35.SGD","BK4588","MAA","BK4081","LU2380233275.USD","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675587876","title":"Press Release: Ecopetrol Continues Advancing Its Transformation Journey with the Appointment of Its New Corporate Compliance Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2675587876","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675587876?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:53","pubTimestamp":1792068780,"startTime":"0","endTime":"0","summary":"BOGOT, Oct. 15, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the \"Company\") announces that its Board of Directors has appointed José Eduardo Barreneche vila as the Company's Corpora","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675341386","title":"Ecopetrol price target raised to $13 from $11 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2675341386","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675341386?lang=en_us&edition=fundamental","pubTime":"2026-10-14 19:55","pubTimestamp":1791978929,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Ecopetrol (EC) to $13 from $11 and keeps an Underperform rating on the shares as the firm rolled its valuati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ecopetrol-price-target-raised-to-13-from-11-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ecopetrol-price-target-raised-to-13-from-11-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675039314","title":"Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2675039314","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675039314?lang=en_us&edition=fundamental","pubTime":"2026-10-14 07:30","pubTimestamp":1791934200,"startTime":"0","endTime":"0","summary":"-- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price list -- -- IMCIVREE is the first approved therapy in Japan f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/13/3380291/0/en/rhythm-pharmaceuticals-announces-commercial-launch-of-imcivree-setmelanotide-in-japan-for-patients-with-acquired-hypothalamic-obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","AVP","NHI","BK4201","BK4157","BK4203","EC","DI","BMI","BK4225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672775135","title":"Press Release: Ecopetrol Group, in Coordination with the National Government, Receives Payment of the Fuel Price Stabilization Fund (fepc, by Its Spanish Acronym) Receivable Corresponding to the Third and Fourth Quarters of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2672775135","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672775135?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":"BOGOT, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) (the \"Company\") hereby announces that, pursuant to coordinated efforts undertaken with the National Government o","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NHLD","EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672087759","title":"Press Release: Ecopetrol Advances Its Transformation with Changes to Its Senior Management Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2672087759","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672087759?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":"BOGOT, Colombia, Oct. 1, 2026 /PRNewswire/ -- Ecopetrol S.A.   announced today that its Board of Directors, at a meeting held on September 30, 2026, approved the appointment of three new members of senior management, as part of the Company's ongoing strategy to strengthen key capabilities for its next phase of development.-- Mónica Jiménez González a ppointed Corporate Vice. President of Legal Affairs and General Secretary. Mónica. Jiménez González will join Ecopetrol as Corporate Vice. President of Legal Affairs and General Secretary, effective no later than. October 6, 2026.Ms. Jiménez brings more than 20 years of experience. in business strategy, corporate law, corporate governance, international. arbitration and sustainability across Latin America and Canada, with a. career focused on the energy sector. Her professional background includes. defining and implementing business strategies through an integrated. Jiménez served as the Company's Corporate Vice President of. Corporate Aff","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","DRIP","NYSE","EC","WTIU","DIG","USE","TISI","VDE","PXE","DRLL","IEO","ERX","BK4120","DBE","BK4201","DBC","XES","PXJ","IXC","BK4585","GUSH","FTXN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670281218","title":"Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=2670281218","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670281218?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:49","pubTimestamp":1790578140,"startTime":"0","endTime":"0","summary":"NANJING, China, Sept.  28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company’s p","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369527/0/en/leads-biolabs-pd-l1-4-1bb-bispecific-antibody-opamtistomig-lbl-024-granted-orphan-drug-designation-in-japan-further-expanding-global-regulatory-recognition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EZBC","BAGY","CBOJ","BTCC","GBTC","CBXJ","ARKB","BITB","IBIT","BITX","BFAP","XHB","BTRN","COAL","CBTO","HCC","YBTC","BTCZ","CBOO","CBXA","BRRR","BCCC","OC","BPI","EC","BTC","BTCO","CBTY","BTCW","CBTJ","CBOA","BETH","MAXI","BTF","QBF","BITY","HODL","CBXY","MNRS","ODD","SBIT","FBTC","BITU","CBOY","BITO","CBXO","BTCL","BFJL","BTCI","XBTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440756","title":"Sector Update: Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440756","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440756?lang=en_us&edition=fundamental","pubTime":"2026-09-25 21:10","pubTimestamp":1790341811,"startTime":"0","endTime":"0","summary":"Energy stocks were falling pre-bell Friday, with the State Street Energy Select Sector SPDR ETF  declining by 1.1%.The United States Oil Fund  was down 2.6% and the United States Natural Gas Fund  was 3% lower.Front-month US West Texas Intermediate crude oil was 2% lower at $92.74 per barrel at the New York Mercantile Exchange. Global benchmark North Sea Brent crude oil fell 1.5% to $104.98 per barrel, and natural gas futures were down 2.5% at $3.29 per 1 million British Thermal Units.Ecopetrol  said its board has unanimously appointed Joaquin Gutierrez Caballero as its chief executive officer and principal legal representative, effective Monday. Shares of Ecopetrol were down more than 1% premarket.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4570","ERX","IEO","UNG","WTIU","DUG","FTXN","PXJ","SCO","DIG","UCO","DRLL","DRIP","DBC","XOP","USE","BK4201","XLE","IXC","EC","XES","BK4585","PXE","USO","VDE","GUSH","DBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670157014","title":"Ecopetrol Names Joaquín Gutiérrez Caballero as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2670157014","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670157014?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:48","pubTimestamp":1790290080,"startTime":"0","endTime":"0","summary":"Ecopetrol named businessman Joaquín Gutiérrez Caballero as chief executive.Caballero will start on Sept. 28, succeeding interim Camilo Barco.His priorities will include advancing Ecopetrol's renewal t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ecopetrol Names Joaquín Gutiérrez Caballero as CEO","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670134764","title":"Ecopetrol Names Joaquin Gutierrez Caballero as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670134764","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670134764?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:21","pubTimestamp":1790284902,"startTime":"0","endTime":"0","summary":"Ecopetrol  said Thursday its board has unanimously appointed Joaquin Gutierrez Caballero as its chief executive officer and principal legal representative, effective Monday.Camilo Barco's appointment as interim CEO will conclude on Sunday, the company said.Ecopetrol said Caballero's appointment was in accordance with its succession policy.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669468397","title":"Market Chatter: Petroleo Brasileiro Awaits Official Nod on Columbia Offshore Gas Project for 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669468397","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669468397?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:01","pubTimestamp":1790236871,"startTime":"0","endTime":"0","summary":"Petroleo Brasileiro (PBR) awaits an official nod to develop an offshore Colombia gas field, as part of its 2027 to 2031 production slate, Reuters reported Wednesday.Petrobas anticipates development of","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1883866441.USD","LU0572108347.SGD","LU0788109048.HKD","LU0086394185.USD","LU0106259046.USD","LU0265266980.USD","BK4585","BK4548","LU1051769294.HKD","PBRG","LU1051768304.USD","BK4588","EC","BK4201","LU0651946864.USD","LU2462611646.USD","LU0072463663.USD","LU0651947912.USD","LU1515016050.SGD","LU0256859116.SGD","LU2498475776.HKD","PBR","IE00B1B80R65.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142897","title":"Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142897","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142897?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"-- First targeted therapy approved in Canada for patients four years and older living with acquired hypothalamic obesity (HO) --BOSTON, Sept.  22, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366284/0/en/rhythm-pharmaceuticals-announces-health-canada-approval-of-imcivree-setmelanotide-for-weight-management-in-adult-and-pediatric-patients-4-years-of-age-and-older-with-acquired-hypot.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","EC","BK4157","BMI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669108166","title":"NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669108166","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669108166?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:00","pubTimestamp":1789995600,"startTime":"0","endTime":"0","summary":"- First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and TANDEM trials demonstrating significant LDL-C reductions with favorable tolerability profile- - First global regulatory approval ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/21/3365512/0/en/newamsterdam-pharma-and-menarini-group-receive-european-commission-approval-for-ubeslo-obicetrapib-monotherapy-and-evlarco-obicetrapib-plus-ezetimibe-fixed-dose-combination.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","CHMP","EPV","EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668924809","title":"Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668924809","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668924809?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:51","pubTimestamp":1789743060,"startTime":"0","endTime":"0","summary":"If approved, Cosentyx (secukinumab) will be first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica (PMR), providing new treatment option after steroidsRecommendation based on","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/18/3364794/0/en/novartis-receives-positive-chmp-opinion-for-cosentyx-in-polymyalgia-rheumatica-pmr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","PMR","AS","BK4202","CHMP","BK4087","EC","EMA","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668295129","title":"Ecopetrol Elects Carlos Suarez as Chairman, Claudia Lafaurie Taboada as Vice Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2668295129","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668295129?lang=en_us&edition=fundamental","pubTime":"2026-09-18 21:38","pubTimestamp":1789738735,"startTime":"0","endTime":"0","summary":"Ecopetrol's (EC) board has appointed Carlos Augusto Suarez Rojas as chairman and Claudia Margarita Lafaurie Taboada as vice chair, the company said Friday.Rojas succeeds Luis Felipe Henao Cardona, Ecopetrol said.Price: 17.11, Change: -0.27, Percent Change: -1.58","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ecopetrol.com.co","stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0428},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.221},{"period":"1year","weight":0.8571},{"period":"ytd","weight":0.7255}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0551},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1232},{"period":"ytd","weight":0.1287}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ecopetrol S.A. operates as an integrated energy company. The company operates through four segments: Exploration and Production; Transport and Logistics; Refining, Petrochemical and Biofuels; and Electric Power Transmission and Toll Roads Concessions. It engages in the exploration and production of oil and gas; transportation of crude oil, motor fuels, fuel oil, and other refined products, including diesel, jet, and biofuels; processing and refining crude oil; distribution of natural gas and LPG; sale of refined and petrochemical products; supplying of electric power transmission services; design, development, construction, operation, and maintenance of road and energy infrastructure projects; and supplying of information technology and telecommunications services. As of December 31, 2022, the company had approximately 9,127 kilometers of crude oil and multi-purpose pipelines. It also produces and commercializes polypropylene resins and compounds, and masterbatches; and offers industrial service sales to customers and specialized management services. It has operations in Colombia, the United States, Asia, Central America and the Caribbean, Europe, and South America. The company was formerly known as Empresa Colombiana de Petróleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was incorporated in 1948 and is headquartered in Bogotá, Colombia.","yearOnYearQuotes":[{"month":1,"riseRate":0.611111,"avgChangeRate":0.047964},{"month":2,"riseRate":0.5,"avgChangeRate":0.012901},{"month":3,"riseRate":0.722222,"avgChangeRate":0.035116},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.012129},{"month":5,"riseRate":0.388889,"avgChangeRate":-0.01423},{"month":6,"riseRate":0.444444,"avgChangeRate":0.004017},{"month":7,"riseRate":0.5,"avgChangeRate":0.017041},{"month":8,"riseRate":0.444444,"avgChangeRate":0.000431},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.011248},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.004114},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.030395},{"month":12,"riseRate":0.611111,"avgChangeRate":0.009975}],"exchange":"NYSE","name":"Ecopetrol SA","nameEN":"Ecopetrol SA","securityTypeName":"DR","adrRate":"1:20"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Ecopetrol SA(EC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Ecopetrol SA,EC,Ecopetrol SA股票,Ecopetrol SA股票老虎,Ecopetrol SA股票老虎国际,Ecopetrol SA行情,Ecopetrol SA股票行情,Ecopetrol SA股价,Ecopetrol SA股市,Ecopetrol SA股票价格,Ecopetrol SA股票交易,Ecopetrol SA股票购买,Ecopetrol SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Ecopetrol SA(EC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction